This is a preview of subscription content, log in via an institution to check access.
Notes
Medulloblastomas arise in the back of the brain and account for about 20% of brain tumors in children.
References
Cytokinetics. Cytokinetics reports data for ispinesib (SB-715992) in platinum-sensitive non-small cell lung cancer. Media release: 30 Mar 2006
Cardiome Pharma. Cardiome Pharma Corp. -New Drug Application submitted for RSD1235. Media release: 31 Mar 2006
St Jude Children’s Research Hospital. Technique could speed new medulloblastoma drugs. Media release: 17 Apr 2006
Columbia University Medical Center. Prostate cancer research may be faster with PSA endpoints. Media release: 18 Apr 2006
University of Texas M. D. Anderson Cancer Center. Lack of response to Herceptin may be reversed with addition of PI3K inhibitor. Media release: 29 Mar 2006
Acacia Research. CombiMatrix granted key nanotechnology patent; patent enables unique proteomics technology and products. Media release: 16 Mar 2006
Isis Pharmaceuticals. Isis Pharmaceuticals receives another important antisense patent. Media release: 27 Mar 2006
Metabolon. Patent positions Metabolon as the leading metabolomics provider for discovery and therapeutic solutions. Media release: 23 Mar 2006
Nanogen. Nanogen earns two patents for therapeutic and diagnostic use of biomarkers. Media release: 17 Apr 2006
Sequenom. Sequenom expands MassARRAY(R) platform utility with launch of quantitative methylation and gene expression analysis products. Media release: 16 Mar 2006
Rights and permissions
About this article
Cite this article
Recent R&D Highlights. Pharmaceutical & Diagnostic Innovation 4, 14–16 (2006). https://doi.org/10.1007/BF03257063
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03257063